AI-Engineered Miniproteins for Targeted Oligonucleotide Delivery: Enabling Receptor-Mediated Uptake Beyond the Liver
2:45 pm - Wednesday 9th December 2026
- Showcase the application of AI-designed miniproteins for siRNA delivery to muscle, including evidence of functional target knockdown
- Examine the key challenges in translating receptor binding and cellular uptake into effective intracellular delivery and pharmacology
- Consider how targeted miniprotein delivery could expand the reach of oligonucleotide therapeutics to tissues and cell types that remain difficult to access
